Penumbra Sale To Boston Scientific Recasts Growth Story For Investors
Penumbra (NYSE:PEN) is set to be acquired by Boston Scientific in a US$14.5b deal, following the release of strong quarterly...
Penumbra
Boston Scientific’s Nalu And Penumbra Bets Reframe Growth And Valuation Profile
Boston Scientific (NYSE:BSX) recently completed its acquisition of Nalu Medical, expanding its presence in pain management devices. The company has...
